Clinical trial

A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)

NCT06605703

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-09-18

PhasePHASE4

Study timeline

Study start (actual)2024-09-18Date precision: day

Registry last updated2026-04-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Overweightunresolved

Interventions

WW ClinicBEHAVIORAL

Bupropion-NaltrexoneDRUG

Bupropion-Naltrexone-MetforminDRUG

Sponsors & collaborators

WW International Inclead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06605703 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.